| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurosurgery | 10 | 2020 | 38 | 3.960 |
Why?
|
| Thrombectomy | 13 | 2021 | 75 | 2.330 |
Why?
|
| Intracranial Aneurysm | 8 | 2020 | 68 | 1.770 |
Why?
|
| Career Choice | 5 | 2019 | 45 | 1.700 |
Why?
|
| Carotid Stenosis | 5 | 2020 | 61 | 1.510 |
Why?
|
| Physicians, Women | 3 | 2018 | 21 | 1.480 |
Why?
|
| Embolization, Therapeutic | 10 | 2017 | 87 | 1.390 |
Why?
|
| Pseudotumor Cerebri | 7 | 2020 | 20 | 1.360 |
Why?
|
| Cranial Sinuses | 7 | 2020 | 19 | 1.360 |
Why?
|
| Internship and Residency | 5 | 2019 | 330 | 1.260 |
Why?
|
| Stents | 13 | 2020 | 167 | 1.090 |
Why?
|
| Burnout, Professional | 4 | 2020 | 55 | 1.000 |
Why?
|
| Stroke | 11 | 2021 | 700 | 0.970 |
Why?
|
| Humans | 72 | 2021 | 34562 | 0.920 |
Why?
|
| Carotid Artery, Internal | 6 | 2018 | 33 | 0.860 |
Why?
|
| Male | 49 | 2021 | 20740 | 0.780 |
Why?
|
| Female | 43 | 2021 | 21532 | 0.730 |
Why?
|
| Treatment Outcome | 27 | 2021 | 3623 | 0.730 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2021 | 46 | 0.700 |
Why?
|
| Retinal Artery Occlusion | 1 | 2020 | 4 | 0.670 |
Why?
|
| Vision, Ocular | 1 | 2020 | 33 | 0.660 |
Why?
|
| Disease Management | 2 | 2019 | 134 | 0.660 |
Why?
|
| Catheterization | 2 | 2010 | 62 | 0.630 |
Why?
|
| Cervical Vertebrae | 3 | 2018 | 54 | 0.630 |
Why?
|
| Physicians | 5 | 2020 | 169 | 0.620 |
Why?
|
| Retrospective Studies | 19 | 2021 | 3825 | 0.610 |
Why?
|
| Aneurysm, Ruptured | 4 | 2018 | 33 | 0.610 |
Why?
|
| Pituitary Neoplasms | 2 | 2010 | 17 | 0.600 |
Why?
|
| Brain Ischemia | 6 | 2021 | 160 | 0.590 |
Why?
|
| Spinal Cord Injuries | 3 | 2009 | 47 | 0.590 |
Why?
|
| Cerebral Revascularization | 2 | 2020 | 10 | 0.580 |
Why?
|
| Craniotomy | 1 | 2018 | 46 | 0.570 |
Why?
|
| Mandibular Condyle | 1 | 2018 | 5 | 0.560 |
Why?
|
| Mental Health | 1 | 2019 | 126 | 0.550 |
Why?
|
| Occipital Bone | 1 | 2018 | 18 | 0.550 |
Why?
|
| Brain Injuries | 1 | 2018 | 94 | 0.550 |
Why?
|
| Aged | 25 | 2021 | 11022 | 0.540 |
Why?
|
| Endarterectomy, Carotid | 1 | 2017 | 29 | 0.540 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2017 | 16 | 0.540 |
Why?
|
| Spinal Fractures | 1 | 2018 | 45 | 0.530 |
Why?
|
| Aneurysm, False | 3 | 2018 | 15 | 0.510 |
Why?
|
| Carotid Artery Diseases | 3 | 2018 | 129 | 0.510 |
Why?
|
| Health Promotion | 1 | 2019 | 264 | 0.500 |
Why?
|
| Adult | 24 | 2020 | 10030 | 0.490 |
Why?
|
| Neurons | 3 | 2009 | 491 | 0.460 |
Why?
|
| Time Factors | 4 | 2020 | 2353 | 0.460 |
Why?
|
| Venous Pressure | 3 | 2020 | 9 | 0.450 |
Why?
|
| Emergency Medical Services | 1 | 2017 | 189 | 0.450 |
Why?
|
| Cost Control | 1 | 2014 | 18 | 0.440 |
Why?
|
| Cerebral Angiography | 7 | 2018 | 60 | 0.440 |
Why?
|
| School Admission Criteria | 1 | 2014 | 11 | 0.430 |
Why?
|
| Middle Aged | 27 | 2021 | 12726 | 0.410 |
Why?
|
| Interviews as Topic | 1 | 2014 | 272 | 0.410 |
Why?
|
| Carotid-Cavernous Sinus Fistula | 2 | 2010 | 2 | 0.400 |
Why?
|
| Intracranial Hypotension | 2 | 2018 | 3 | 0.400 |
Why?
|
| Students, Medical | 1 | 2014 | 136 | 0.380 |
Why?
|
| Phlebography | 4 | 2020 | 27 | 0.360 |
Why?
|
| Oculomotor Nerve | 1 | 2011 | 4 | 0.350 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 1 | 2011 | 6 | 0.350 |
Why?
|
| Neurosurgical Procedures | 7 | 2020 | 101 | 0.350 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2011 | 30 | 0.340 |
Why?
|
| Blood Pressure | 3 | 2020 | 901 | 0.340 |
Why?
|
| gamma-Aminobutyric Acid | 3 | 2009 | 83 | 0.330 |
Why?
|
| Polyvinyls | 4 | 2011 | 7 | 0.330 |
Why?
|
| Angiography | 6 | 2018 | 79 | 0.330 |
Why?
|
| Central Nervous System Cysts | 1 | 2010 | 2 | 0.320 |
Why?
|
| Craniopharyngioma | 1 | 2010 | 8 | 0.320 |
Why?
|
| Orbit | 1 | 2010 | 19 | 0.320 |
Why?
|
| Veins | 1 | 2010 | 35 | 0.320 |
Why?
|
| Ossification, Heterotopic | 1 | 2010 | 21 | 0.310 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2010 | 63 | 0.310 |
Why?
|
| Blood Coagulation Disorders | 1 | 2009 | 11 | 0.310 |
Why?
|
| Thrombocytopenia | 1 | 2009 | 33 | 0.310 |
Why?
|
| Hemangioma | 1 | 2009 | 24 | 0.300 |
Why?
|
| Scalp | 1 | 2009 | 38 | 0.300 |
Why?
|
| Job Satisfaction | 2 | 2020 | 42 | 0.300 |
Why?
|
| Carbon Dioxide | 2 | 2020 | 40 | 0.290 |
Why?
|
| Ventriculoperitoneal Shunt | 2 | 2018 | 8 | 0.290 |
Why?
|
| Manometry | 2 | 2019 | 24 | 0.290 |
Why?
|
| Health Personnel | 2 | 2020 | 131 | 0.290 |
Why?
|
| Femoral Artery | 2 | 2020 | 50 | 0.290 |
Why?
|
| United States | 8 | 2020 | 4278 | 0.290 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 98 | 0.290 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 103 | 0.290 |
Why?
|
| Cerebral Hemorrhage | 2 | 2019 | 72 | 0.290 |
Why?
|
| Neuralgia | 1 | 2009 | 47 | 0.280 |
Why?
|
| Cerebral Veins | 1 | 2008 | 12 | 0.280 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2008 | 21 | 0.280 |
Why?
|
| Arteriovenous Fistula | 1 | 2008 | 19 | 0.280 |
Why?
|
| Intracranial Embolism | 1 | 2008 | 15 | 0.270 |
Why?
|
| Angiography, Digital Subtraction | 3 | 2020 | 19 | 0.260 |
Why?
|
| Brain Tissue Transplantation | 1 | 2007 | 3 | 0.260 |
Why?
|
| Epidural Space | 1 | 2007 | 9 | 0.260 |
Why?
|
| Pain, Intractable | 1 | 2007 | 3 | 0.260 |
Why?
|
| Spinal Cord Compression | 1 | 2007 | 7 | 0.260 |
Why?
|
| Hyperemia | 1 | 2007 | 11 | 0.260 |
Why?
|
| Skin Neoplasms | 1 | 2009 | 225 | 0.260 |
Why?
|
| Prospective Studies | 11 | 2021 | 2463 | 0.260 |
Why?
|
| Glioma | 1 | 2008 | 138 | 0.250 |
Why?
|
| Retinoblastoma | 3 | 2011 | 8 | 0.250 |
Why?
|
| Retinal Neoplasms | 3 | 2011 | 9 | 0.250 |
Why?
|
| Dimethyl Sulfoxide | 3 | 2010 | 13 | 0.240 |
Why?
|
| Fibroma, Desmoplastic | 1 | 2005 | 1 | 0.230 |
Why?
|
| Skull Neoplasms | 1 | 2005 | 4 | 0.230 |
Why?
|
| Magnetic Resonance Angiography | 3 | 2011 | 79 | 0.230 |
Why?
|
| Intracranial Pressure | 3 | 2019 | 17 | 0.220 |
Why?
|
| Wounds, Nonpenetrating | 2 | 2017 | 88 | 0.210 |
Why?
|
| Recovery of Function | 2 | 2020 | 251 | 0.210 |
Why?
|
| Follow-Up Studies | 5 | 2020 | 2367 | 0.200 |
Why?
|
| Vascular Surgical Procedures | 2 | 2017 | 90 | 0.200 |
Why?
|
| Aged, 80 and over | 9 | 2021 | 4157 | 0.200 |
Why?
|
| Reperfusion | 2 | 2020 | 21 | 0.200 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2021 | 94 | 0.200 |
Why?
|
| Reoperation | 2 | 2017 | 265 | 0.200 |
Why?
|
| Diagnosis, Differential | 4 | 2017 | 542 | 0.180 |
Why?
|
| Pilot Projects | 3 | 2020 | 585 | 0.180 |
Why?
|
| Thrombolytic Therapy | 2 | 2020 | 67 | 0.180 |
Why?
|
| Hospitals | 2 | 2019 | 105 | 0.180 |
Why?
|
| Tantalum | 2 | 2011 | 3 | 0.170 |
Why?
|
| Heparin | 1 | 2021 | 74 | 0.160 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2020 | 34 | 0.160 |
Why?
|
| Independent Living | 2 | 2020 | 95 | 0.160 |
Why?
|
| Referral and Consultation | 2 | 2019 | 149 | 0.160 |
Why?
|
| Retreatment | 1 | 2020 | 43 | 0.160 |
Why?
|
| Radial Artery | 1 | 2020 | 16 | 0.160 |
Why?
|
| Lumbar Vertebrae | 2 | 2018 | 114 | 0.160 |
Why?
|
| Physician's Role | 1 | 2020 | 41 | 0.160 |
Why?
|
| Postoperative Complications | 3 | 2020 | 850 | 0.160 |
Why?
|
| Carotid Arteries | 1 | 2020 | 116 | 0.160 |
Why?
|
| Cohort Studies | 3 | 2020 | 1910 | 0.160 |
Why?
|
| Periodicals as Topic | 2 | 2019 | 91 | 0.160 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2019 | 19 | 0.150 |
Why?
|
| Rats, Inbred WF | 3 | 2009 | 8 | 0.150 |
Why?
|
| Databases, Factual | 2 | 2018 | 380 | 0.150 |
Why?
|
| Bibliometrics | 1 | 2019 | 11 | 0.150 |
Why?
|
| Thrombosis | 1 | 2019 | 88 | 0.150 |
Why?
|
| Decompressive Craniectomy | 1 | 2018 | 5 | 0.150 |
Why?
|
| Attitude of Health Personnel | 1 | 2020 | 193 | 0.140 |
Why?
|
| Superior Sagittal Sinus | 1 | 2018 | 6 | 0.140 |
Why?
|
| Infant | 4 | 2014 | 1123 | 0.140 |
Why?
|
| Transverse Sinuses | 1 | 2018 | 5 | 0.140 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 176 | 0.140 |
Why?
|
| Healthcare Disparities | 1 | 2021 | 183 | 0.140 |
Why?
|
| Lordosis | 1 | 2018 | 2 | 0.140 |
Why?
|
| Cell Line | 3 | 2009 | 476 | 0.140 |
Why?
|
| Hypertension | 3 | 2020 | 1024 | 0.140 |
Why?
|
| Intracranial Hypertension | 1 | 2018 | 21 | 0.140 |
Why?
|
| Faculty | 1 | 2018 | 16 | 0.140 |
Why?
|
| Vascular Diseases | 1 | 2018 | 69 | 0.140 |
Why?
|
| Workload | 1 | 2018 | 40 | 0.140 |
Why?
|
| Certification | 1 | 2018 | 30 | 0.140 |
Why?
|
| Respiration, Artificial | 1 | 2018 | 105 | 0.140 |
Why?
|
| Cerebrovascular Disorders | 1 | 2018 | 55 | 0.130 |
Why?
|
| Infusions, Intravenous | 1 | 2017 | 110 | 0.130 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2017 | 25 | 0.130 |
Why?
|
| Risk Factors | 3 | 2021 | 4137 | 0.130 |
Why?
|
| Feasibility Studies | 2 | 2017 | 323 | 0.130 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2011 | 1393 | 0.130 |
Why?
|
| Subarachnoid Space | 2 | 2007 | 5 | 0.130 |
Why?
|
| Drug Administration Schedule | 1 | 2017 | 306 | 0.130 |
Why?
|
| Cooperative Behavior | 1 | 2017 | 87 | 0.130 |
Why?
|
| Patient Selection | 1 | 2018 | 291 | 0.120 |
Why?
|
| Hyperalgesia | 2 | 2007 | 86 | 0.120 |
Why?
|
| Child | 5 | 2014 | 2614 | 0.120 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 230 | 0.120 |
Why?
|
| Quality Assurance, Health Care | 1 | 2016 | 76 | 0.120 |
Why?
|
| Decision Support Techniques | 1 | 2017 | 136 | 0.120 |
Why?
|
| Biomedical Research | 1 | 2017 | 186 | 0.120 |
Why?
|
| Personnel Selection | 1 | 2015 | 16 | 0.120 |
Why?
|
| Contrast Media | 1 | 2016 | 149 | 0.120 |
Why?
|
| Risk Assessment | 1 | 2020 | 1508 | 0.110 |
Why?
|
| Rats | 3 | 2009 | 1946 | 0.110 |
Why?
|
| Internet | 1 | 2016 | 207 | 0.110 |
Why?
|
| Transportation | 1 | 2014 | 13 | 0.110 |
Why?
|
| Quality of Life | 1 | 2020 | 1032 | 0.110 |
Why?
|
| Angioplasty, Balloon | 2 | 2019 | 33 | 0.110 |
Why?
|
| Constriction, Pathologic | 3 | 2018 | 47 | 0.100 |
Why?
|
| Housing | 1 | 2014 | 65 | 0.100 |
Why?
|
| African Americans | 1 | 2021 | 1435 | 0.100 |
Why?
|
| Weight Lifting | 1 | 2013 | 9 | 0.100 |
Why?
|
| Head Movements | 1 | 2013 | 15 | 0.100 |
Why?
|
| Vertebral Artery | 1 | 2013 | 7 | 0.100 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2013 | 7 | 0.100 |
Why?
|
| Carotid Artery Injuries | 1 | 2013 | 7 | 0.100 |
Why?
|
| Neck Muscles | 1 | 2013 | 8 | 0.100 |
Why?
|
| Sex Factors | 1 | 2015 | 708 | 0.100 |
Why?
|
| Intraoperative Complications | 2 | 2010 | 62 | 0.100 |
Why?
|
| Accidental Falls | 1 | 2014 | 116 | 0.100 |
Why?
|
| Quisqualic Acid | 2 | 2009 | 2 | 0.090 |
Why?
|
| Excitatory Amino Acid Agonists | 2 | 2009 | 18 | 0.090 |
Why?
|
| Glycine | 2 | 2009 | 31 | 0.090 |
Why?
|
| Spinal Cord Diseases | 1 | 2011 | 14 | 0.090 |
Why?
|
| Oculomotor Nerve Diseases | 1 | 2011 | 3 | 0.090 |
Why?
|
| Wounds and Injuries | 1 | 2014 | 248 | 0.090 |
Why?
|
| Angiofibroma | 1 | 2011 | 2 | 0.090 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2011 | 5 | 0.090 |
Why?
|
| Abscess | 1 | 2011 | 28 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2013 | 988 | 0.080 |
Why?
|
| Ophthalmic Artery | 1 | 2010 | 9 | 0.080 |
Why?
|
| Retinal Artery | 1 | 2010 | 6 | 0.080 |
Why?
|
| Laser Coagulation | 1 | 2010 | 13 | 0.080 |
Why?
|
| Ligation | 1 | 2010 | 65 | 0.080 |
Why?
|
| Carotid Artery, Common | 1 | 2010 | 49 | 0.080 |
Why?
|
| Cavernous Sinus | 1 | 2010 | 2 | 0.080 |
Why?
|
| Eyelids | 1 | 2010 | 8 | 0.080 |
Why?
|
| Pituitary Gland | 1 | 2010 | 10 | 0.080 |
Why?
|
| Preoperative Care | 1 | 2011 | 129 | 0.080 |
Why?
|
| Forehead | 1 | 2010 | 13 | 0.080 |
Why?
|
| Mitosis | 1 | 2010 | 26 | 0.080 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2010 | 14 | 0.080 |
Why?
|
| Vascular Neoplasms | 1 | 2010 | 12 | 0.080 |
Why?
|
| Melphalan | 1 | 2010 | 8 | 0.080 |
Why?
|
| Child, Preschool | 3 | 2014 | 1355 | 0.080 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2010 | 45 | 0.080 |
Why?
|
| Immunohistochemistry | 2 | 2009 | 600 | 0.080 |
Why?
|
| Equipment Design | 1 | 2010 | 192 | 0.080 |
Why?
|
| Syndrome | 1 | 2009 | 76 | 0.080 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2010 | 137 | 0.080 |
Why?
|
| Hospital Mortality | 2 | 2021 | 207 | 0.070 |
Why?
|
| Anesthesia, General | 2 | 2020 | 35 | 0.070 |
Why?
|
| Radiography | 1 | 2010 | 397 | 0.070 |
Why?
|
| Blood Pressure Determination | 2 | 2019 | 108 | 0.070 |
Why?
|
| Registries | 2 | 2021 | 328 | 0.070 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2010 | 260 | 0.070 |
Why?
|
| Young Adult | 4 | 2020 | 2831 | 0.070 |
Why?
|
| Spinal Cord | 1 | 2009 | 150 | 0.070 |
Why?
|
| Publishing | 2 | 2019 | 66 | 0.070 |
Why?
|
| Cell Differentiation | 2 | 2007 | 485 | 0.070 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2008 | 65 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2010 | 402 | 0.070 |
Why?
|
| Animals | 3 | 2009 | 8579 | 0.070 |
Why?
|
| Prevalence | 2 | 2020 | 1034 | 0.070 |
Why?
|
| Hydrocephalus | 1 | 2007 | 12 | 0.060 |
Why?
|
| Pia Mater | 1 | 2007 | 2 | 0.060 |
Why?
|
| Calcinosis | 1 | 2008 | 150 | 0.060 |
Why?
|
| Behavior, Animal | 1 | 2009 | 303 | 0.060 |
Why?
|
| Cell Count | 1 | 2007 | 55 | 0.060 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2010 | 491 | 0.060 |
Why?
|
| Cell Transplantation | 1 | 2007 | 65 | 0.060 |
Why?
|
| Adolescent | 3 | 2011 | 3805 | 0.060 |
Why?
|
| Microsurgery | 1 | 2006 | 22 | 0.060 |
Why?
|
| Graft Survival | 1 | 2007 | 315 | 0.060 |
Why?
|
| Prognosis | 2 | 2020 | 1606 | 0.050 |
Why?
|
| Internationality | 1 | 2021 | 24 | 0.040 |
Why?
|
| Workflow | 1 | 2020 | 22 | 0.040 |
Why?
|
| Catheterization, Peripheral | 1 | 2020 | 29 | 0.040 |
Why?
|
| Goals | 1 | 2020 | 36 | 0.040 |
Why?
|
| Journal Impact Factor | 1 | 2019 | 11 | 0.040 |
Why?
|
| Linear Models | 1 | 2020 | 465 | 0.040 |
Why?
|
| Fibrinolytic Agents | 1 | 2019 | 71 | 0.040 |
Why?
|
| Intention to Treat Analysis | 1 | 2019 | 29 | 0.040 |
Why?
|
| Personal Satisfaction | 1 | 2019 | 28 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 2011 | 590 | 0.040 |
Why?
|
| Paranasal Sinuses | 1 | 2018 | 3 | 0.040 |
Why?
|
| Blister | 1 | 2018 | 7 | 0.030 |
Why?
|
| Terminology as Topic | 1 | 2018 | 71 | 0.030 |
Why?
|
| Headache | 1 | 2018 | 78 | 0.030 |
Why?
|
| Consensus | 1 | 2018 | 92 | 0.030 |
Why?
|
| Hospitalization | 1 | 2021 | 500 | 0.030 |
Why?
|
| International Cooperation | 1 | 2017 | 33 | 0.030 |
Why?
|
| China | 1 | 2017 | 58 | 0.030 |
Why?
|
| Canada | 1 | 2017 | 69 | 0.030 |
Why?
|
| Patient Admission | 1 | 2017 | 59 | 0.030 |
Why?
|
| Hip Joint | 1 | 2016 | 70 | 0.030 |
Why?
|
| Risk | 1 | 2016 | 325 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2017 | 214 | 0.030 |
Why?
|
| Orthopedic Procedures | 1 | 2016 | 101 | 0.030 |
Why?
|
| Knee Joint | 1 | 2016 | 151 | 0.030 |
Why?
|
| Length of Stay | 1 | 2016 | 335 | 0.030 |
Why?
|
| Logistic Models | 1 | 2017 | 808 | 0.030 |
Why?
|
| Hawaii | 1 | 2014 | 5 | 0.030 |
Why?
|
| Accidents, Aviation | 1 | 2013 | 1 | 0.030 |
Why?
|
| Aircraft | 1 | 2013 | 6 | 0.030 |
Why?
|
| Hypertrophy | 1 | 2013 | 36 | 0.030 |
Why?
|
| Regional Blood Flow | 1 | 2013 | 95 | 0.030 |
Why?
|
| Rotation | 1 | 2013 | 54 | 0.030 |
Why?
|
| Age Factors | 1 | 2017 | 1262 | 0.030 |
Why?
|
| Gram-Positive Cocci | 1 | 2011 | 4 | 0.020 |
Why?
|
| Laminectomy | 1 | 2011 | 17 | 0.020 |
Why?
|
| Paresis | 1 | 2011 | 18 | 0.020 |
Why?
|
| Nasopharynx | 1 | 2011 | 10 | 0.020 |
Why?
|
| Necrosis | 1 | 2011 | 55 | 0.020 |
Why?
|
| Spine | 1 | 2011 | 47 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2011 | 80 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2011 | 107 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 939 | 0.020 |
Why?
|
| Endoscopy | 1 | 2011 | 56 | 0.020 |
Why?
|
| Injections, Intra-Arterial | 1 | 2010 | 7 | 0.020 |
Why?
|
| Sclerosis | 1 | 2010 | 11 | 0.020 |
Why?
|
| Cyclosporine | 1 | 2010 | 49 | 0.020 |
Why?
|
| Vincristine | 1 | 2010 | 26 | 0.020 |
Why?
|
| Fluorescein Angiography | 1 | 2010 | 18 | 0.020 |
Why?
|
| Etoposide | 1 | 2010 | 43 | 0.020 |
Why?
|
| Carboplatin | 1 | 2010 | 55 | 0.020 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2010 | 6 | 0.020 |
Why?
|
| Remission Induction | 1 | 2010 | 97 | 0.020 |
Why?
|
| Blood Loss, Surgical | 1 | 2010 | 55 | 0.020 |
Why?
|
| Visual Acuity | 1 | 2010 | 76 | 0.020 |
Why?
|
| Chemotherapy, Cancer, Regional Perfusion | 1 | 2010 | 155 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2010 | 486 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 2007 | 6 | 0.020 |
Why?
|
| Antimetabolites | 1 | 2007 | 11 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2007 | 97 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2007 | 89 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2007 | 385 | 0.010 |
Why?
|
| Phenotype | 1 | 2007 | 657 | 0.010 |
Why?
|
| Pain | 1 | 2007 | 330 | 0.010 |
Why?
|